We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
MBRX icon
476
Moleculin Biotech
MBRX
$14.4M
$14.4M $0.7400 1.54%
DARE icon
477
Dare Bioscience
DARE
$14.3M
$14.3M $0.7255 0.63%
ENLV icon
478
Enlivex Ltd
ENLV
$14.2M
$14.2M $0.8111 8.11%
GTBP icon
479
GT Biopharma
GTBP
$14.1M
$14.1M $7.81 13.2%
PLUR icon
480
Pluri
PLUR
$14.1M
$14.1M $1.14 2.56%
QNRX
481
Quoin Pharmaceuticals
QNRX
$13.9M
$13.9M $6.90 1.47%
HIND
482
Vyome Holdings
HIND
$13.7M
$13.7M $1.95 2.99%
ICU icon
483
SeaStar Medical
ICU
$13.6M
$13.6M $3.08 1.99%
CALC icon
484
CalciMedica
CALC
$13.5M
$13.5M $1.98 0%
LSTA icon
485
Lisata Therapeutics
LSTA
$13.2M
$13.2M $1.47 4.55%
INTS icon
486
Intensity Therapeutics
INTS
$12.4M
$12.4M $3.81 0%
NRSN icon
487
NeuroSense Therapeutics
NRSN
$12.3M
$12.3M $6.49 7.68%
ASBP
488
Aspire-Lakewood Holdings, Inc. Common Stock
ASBP
$12M
$12M $8.58 4.63%
BLRX
489
BioLineRX
BLRX
$12M
$12M $2.48 1.59%
PHIO icon
490
Phio Pharmaceuticals
PHIO
$11.6M
$11.6M $0.9991 2.05%
KPRX icon
491
Kiora Pharmaceuticals
KPRX
$11.5M
$11.5M $2.60 0%
GDTC icon
492
CytoMed Therapeutics
GDTC
$10.5M
$10.5M $0.8860 10%
VTGN icon
493
VistaGen Therapeutics
VTGN
$10.2M
$10.2M $0.2306 2.33%
MTVA
494
MetaVia Inc
MTVA
$10.1M
$10.1M $1.54 2.53%
KALA icon
495
KALA BIO
KALA
$10.1M
$10.1M $0.5216 2.74%
INAB icon
496
IN8bio
INAB
$9.96M
$9.96M $1.01 3.81%
LNAI
497
Lunai Bioworks
LNAI
$9.84M
$9.84M $2.17 0.91%
SNTI icon
498
Senti Biosciences Holdings
SNTI
$9.7M
$9.7M $0.3113 3.77%
IMRN
499
Immuron
IMRN
$9.6M
$9.6M $1.19 4.03%
FBLG icon
500
FibroBiologics
FBLG
$9.52M
$9.52M $1.43 0.69%
18 19
20
21 22

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.29T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $130B, Regeneron Pharmaceuticals (REGN) at $79.7B and argenx (ARGX) at $61.6B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 245 funds opened new positions, taking total fund holders up 179 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.